Stay updated on Nivolumab for Stage IIB-IIC Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page presents details for a completed Phase 2 nivolumab trial for resected stage IIB–IIC melanoma, including eligibility criteria, treatment plan, outcomes, and study locations. It also includes record dates, investigator and sponsor information, and links to the study protocol.
    Difference
    49%
    Check dated 2026-11-08T14:45:19.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:54:01.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A banner announces an NIH-wide transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The clinical trial page content remains a 403 error.
    Difference
    1%
    Check dated 2026-10-25T17:52:26.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-18T22:29:19.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T22:20:37.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the previous study details and related metadata with an access-denied message. As a result, the clinical trial record is no longer viewable on the page.
    Difference
    18%
    Check dated 2026-09-20T22:41:54.000Z thumbnail image

Stay in the know with updates to Nivolumab for Stage IIB-IIC Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page.